Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Safety and Efficacy Study of a New Formulation of Acetylcysteine Injection

ClinicalTrials.gov ID: NCT01118663

Public ClinicalTrials.gov record NCT01118663. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 7:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Double-blind, Randomized, Controlled Study to Determine the Efficacy and Safety of a New Formulation of Acetylcysteine Injection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is determine if a new formulation of Acetadote is at least as effective as the current formulation in the prevention and treatment of acetaminophen overdose related liver injury.

Study identification

NCT ID
NCT01118663
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cumberland Pharmaceuticals
Industry
Enrollment
17 participants

Conditions and interventions

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Nov 2012 (Actual)
Completion
May 2013 (Actual)
Last update posted
Aug 4, 2014

2010 – 2013

United States locations

U.S. sites
14
U.S. states
10
U.S. cities
14
Facility City State ZIP Site status
Maricopa Medical Center Phoenix Arizona 85008 —
Loma Linda University Medical Center Loma Linda California 92350 —
University of California Irvine Medical Center Orange California 92868 —
UCSD Medical Center San Diego California 92103 —
University of Colorado Hospital Aurora Colorado 80045 —
Denver Health and Hospital Authority Denver Colorado 80204 —
Hartford Hospital Hartford Connecticut 06102 —
LSU Health Sciences Center - Shreveport Shreveport Louisiana 71130 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
UMass Memorial Medical Center Worcester Massachusetts 01655 —
Spectrum Health Butterworth Hospital Grand Rapids Michigan 44506 —
East Carolina University Medical Center Greenville North Carolina 27834 —
Toledo Hospital Toledo Ohio 43606 —
Scott & White Medical Center Temple Texas 76508 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01118663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 4, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01118663 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →